• About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
Strategic Wealth Pro
Advertisement
  • Business
  • Politics
  • Investing
  • Stocks
No Result
View All Result
  • Business
  • Politics
  • Investing
  • Stocks
No Result
View All Result
Strategic Wealth Pro
No Result
View All Result
Home Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

July 28, 2025
in Investing
0
RAD receives IND approval from US FDA for Betabart (RV-01)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Previous Post

Asara raises $25m to accelerate exploration at Kada

 Next Post

GTI Energy
Next Post
GTI Energy

GTI Energy

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 strategicwealthpro.com | All Rights Reserved

    No Result
    View All Result
    • Business
    • Politics
    • Investing
    • Stocks

    Copyright © 2025 strategicwealthpro.com | All Rights Reserved